SALT LAKE CITY, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and financial results for its third quarter ended September 30, 2025.
Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update
Seeking Alpha / 59 minutes from now 3 Views
Comments